Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5997194 | 1.00 | PPARA (0.41) | PPARATSHRALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL5996223 | 1.00 | PPARA (0.41) | PPARATSHRALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL5994221 | 1.00 | PPARA (0.41) | PPARATSHRALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL5993368 | 0.99 | PPARA (0.39) | PPARATSHRALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL5997376 | 0.96 | PPARA (0.37) | PPARATSHRALDH1A1SMN1; SMN2NPSR1 | |
| SCHEMBL5993880 | 0.92 | CA12 (0.35) | PPARATSHRALDH1A1SMN1; SMN2NPSR1 | |
| SCHEMBL5996986 | 0.87 | PPARA (0.45) | PPARATSHRALDH1A1LMNA | |
| SCHEMBL5997321 | 0.87 | PPARA (0.45) | PPARATSHRALDH1A1LMNA | |
| SCHEMBL5997226 | 0.87 | PPARA (0.45) | PPARATSHRALDH1A1LMNA | |
| SCHEMBL5998037 | 0.87 | PPARA (0.45) | PPARATSHRALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7026017-B2 | Photoinitiators for acrylic esters; reacting an acyl halide with a metal benzoyl phosphine; cable coatings, screen printing stencils, resist materials, colour filters, electrical encapsulation | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2006-04-11 | — | — | US | disclosed |
| US-6969733-B2 | Photoinitiators | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2005-11-29 | — | — | US | disclosed |
| US-6737549-B2 | PHOTOINITIATORS FOR ACRYLATE COATINGS | CIBA SPECIALTY CHEMICALS CORPORATION | 2004-05-18 | — | — | US | disclosed |
| US-20030139485-A1 | Photoinitiators | WOLF JEAN-PIERRE (CH) | 2003-07-24 | — | — | US | disclosed |
| US-20030130370-A1 | Photoinitiators for acrylic esters; reacting an acyl halide with a metal benzoyl phosphine; cable coatings, screen printing stencils, resist materials, colour filters, electrical encapsulation | WOLF JEAN-PIERRE (CH) | 2003-07-10 | — | — | US | disclosed |
| US-20020026049-A1 | Photoinitiators for acrylate coatings | CIBA SPECIALTY CHEMICALS CORP. | 2002-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030139485-A1 | Photoinitiators | DHCR24, NR1I3, CBR1 | PPARA 1123/4885TSHR 1096/4885ALDH1A1 974/4885 |
| US-20030130370-A1 | Photoinitiators for acrylic esters; reacting an acyl halide with a metal benzoyl phosphine; cable coatings, screen printing stencils, resist materials, colour filters, electrical encapsulation | SMARCC1, ARPC5L, DHCR24 | PPARA 2606/4885TSHR 4029/4885ALDH1A1 1088/4885 |
| US-20020026049-A1 | Photoinitiators for acrylate coatings | DHCR24, NR5A1, NR2C2 | PPARA 2465/4885TSHR 1670/4885ALDH1A1 835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.